ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Via Christi’s Structural Heart team was the first in the nation to participate in the U.S. pivotal trial of Abbott’s Tendyne transcatheter mitral valve replacement system in its hybrid OR, built in ...
Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne") a privately held clinical stage ...
Tendyne’s self-expanding valve replacement includes a dual-frame design—an inner bioprosthetic, plus an outer ring that contours to the shape of the patient’s natural mitral valve—and is available in ...
SAN FRANCISCO -- Operators had a favorable early experience using the Tendyne transcatheter mitral valve replacement (TMVR) system for severe mitral regurgitation (MR) and mitral annular calcification ...
Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported. Several valve repair and replacement technologies, ...
Tendyne Holdings, Inc. (“Tendyne”), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 ...
Minneapolis Heart Institute Foundation (MHIF) physicians are conducting a research study using the first transcatheter mitral valve replacement in the U.S. at Minneapolis Heart Institute at Abbott ...
Transcatheter implantation of the Tendyne mitral valve replacement device for treatment of mitral regurgitation in patients at prohibitive surgical risk because of severe mitral annular calcification ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results